Get Premium to unlock powerful stock data

Parkman Healthcare Partners LLC Buys UnitedHealth Group Inc, CVS Health Corp, HCA Healthcare Inc, Sells Humana Inc, DexCom Inc, Aclaris Therapeutics Inc

Author's Avatar
Feb 19, 2022
Article's Main Image
Investment company Parkman Healthcare Partners LLC (Current Portfolio) buys UnitedHealth Group Inc, CVS Health Corp, HCA Healthcare Inc, Danaher Corp, BioCryst Pharmaceuticals Inc, sells Humana Inc, DexCom Inc, Aclaris Therapeutics Inc, Insulet Corp, Amgen Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Parkman Healthcare Partners LLC. As of 2021Q4, Parkman Healthcare Partners LLC owns 84 stocks with a total value of $453 million. These are the details of the buys and sells.

For the details of Parkman Healthcare Partners LLC's stock buys and sells, go to https://www.gurufocus.com/guru/parkman+healthcare+partners+llc/current-portfolio/portfolio

These are the top 5 holdings of Parkman Healthcare Partners LLC
  1. IQVIA Holdings Inc (IQV) - 73,112 shares, 4.55% of the total portfolio. Shares added by 4.64%
  2. United Therapeutics Corp (UTHR) - 90,198 shares, 4.30% of the total portfolio. Shares reduced by 4.37%
  3. Danaher Corp (DHR) - 58,847 shares, 4.27% of the total portfolio. Shares added by 29.84%
  4. UnitedHealth Group Inc (UNH) - 37,823 shares, 4.19% of the total portfolio. New Position
  5. DexCom Inc (DXCM) - 32,906 shares, 3.90% of the total portfolio. Shares reduced by 27.61%
New Purchase: UnitedHealth Group Inc (UNH)

Parkman Healthcare Partners LLC initiated holding in UnitedHealth Group Inc. The purchase prices were between $387.01 and $505.58, with an estimated average price of $454.21. The stock is now traded at around $467.810000. The impact to a portfolio due to this purchase was 4.19%. The holding were 37,823 shares as of 2021-12-31.

New Purchase: CVS Health Corp (CVS)

Parkman Healthcare Partners LLC initiated holding in CVS Health Corp. The purchase prices were between $83.15 and $103.7, with an estimated average price of $92.68. The stock is now traded at around $102.130000. The impact to a portfolio due to this purchase was 3.04%. The holding were 133,334 shares as of 2021-12-31.

New Purchase: HCA Healthcare Inc (HCA)

Parkman Healthcare Partners LLC initiated holding in HCA Healthcare Inc. The purchase prices were between $225.59 and $260, with an estimated average price of $244.69. The stock is now traded at around $244.100000. The impact to a portfolio due to this purchase was 2.87%. The holding were 50,661 shares as of 2021-12-31.

New Purchase: Keros Therapeutics Inc (KROS)

Parkman Healthcare Partners LLC initiated holding in Keros Therapeutics Inc. The purchase prices were between $36.95 and $62.89, with an estimated average price of $50.29. The stock is now traded at around $52.090000. The impact to a portfolio due to this purchase was 0.9%. The holding were 69,861 shares as of 2021-12-31.

New Purchase: Tenet Healthcare Corp (THC)

Parkman Healthcare Partners LLC initiated holding in Tenet Healthcare Corp. The purchase prices were between $61.02 and $81.91, with an estimated average price of $73.32. The stock is now traded at around $80.510000. The impact to a portfolio due to this purchase was 0.72%. The holding were 40,000 shares as of 2021-12-31.

New Purchase: Imago BioSciences Inc (IMGO)

Parkman Healthcare Partners LLC initiated holding in Imago BioSciences Inc. The purchase prices were between $16.22 and $29.69, with an estimated average price of $23.2. The stock is now traded at around $21.960000. The impact to a portfolio due to this purchase was 0.58%. The holding were 110,000 shares as of 2021-12-31.

Added: Danaher Corp (DHR)

Parkman Healthcare Partners LLC added to a holding in Danaher Corp by 29.84%. The purchase prices were between $292.08 and $329.01, with an estimated average price of $311.04. The stock is now traded at around $266.930000. The impact to a portfolio due to this purchase was 0.98%. The holding were 58,847 shares as of 2021-12-31.

Added: BioCryst Pharmaceuticals Inc (BCRX)

Parkman Healthcare Partners LLC added to a holding in BioCryst Pharmaceuticals Inc by 292.31%. The purchase prices were between $11.18 and $15.46, with an estimated average price of $13.23. The stock is now traded at around $18.740000. The impact to a portfolio due to this purchase was 0.91%. The holding were 400,001 shares as of 2021-12-31.

Added: R1 RCM Inc (RCM)

Parkman Healthcare Partners LLC added to a holding in R1 RCM Inc by 107.17%. The purchase prices were between $21.2 and $26.24, with an estimated average price of $24.01. The stock is now traded at around $26.380000. The impact to a portfolio due to this purchase was 0.87%. The holding were 300,395 shares as of 2021-12-31.

Added: iRhythm Technologies Inc (IRTC)

Parkman Healthcare Partners LLC added to a holding in iRhythm Technologies Inc by 90.71%. The purchase prices were between $58.34 and $122.12, with an estimated average price of $92.77. The stock is now traded at around $112.920000. The impact to a portfolio due to this purchase was 0.77%. The holding were 61,980 shares as of 2021-12-31.

Added: Natera Inc (NTRA)

Parkman Healthcare Partners LLC added to a holding in Natera Inc by 38.32%. The purchase prices were between $86.26 and $119, with an estimated average price of $103.38. The stock is now traded at around $63.890000. The impact to a portfolio due to this purchase was 0.71%. The holding were 124,550 shares as of 2021-12-31.

Added: Catalent Inc (CTLT)

Parkman Healthcare Partners LLC added to a holding in Catalent Inc by 53.35%. The purchase prices were between $119.57 and $139.07, with an estimated average price of $128.41. The stock is now traded at around $99.040000. The impact to a portfolio due to this purchase was 0.6%. The holding were 60,939 shares as of 2021-12-31.

Sold Out: Humana Inc (HUM)

Parkman Healthcare Partners LLC sold out a holding in Humana Inc. The sale prices were between $384.96 and $469.02, with an estimated average price of $443.48.

Sold Out: Amgen Inc (AMGN)

Parkman Healthcare Partners LLC sold out a holding in Amgen Inc. The sale prices were between $198.88 and $227.6, with an estimated average price of $211.1.

Sold Out: (DRNA)

Parkman Healthcare Partners LLC sold out a holding in . The sale prices were between $19.26 and $38.25, with an estimated average price of $29.18.

Sold Out: Inotiv Inc (NOTV)

Parkman Healthcare Partners LLC sold out a holding in Inotiv Inc. The sale prices were between $30.55 and $57.88, with an estimated average price of $45.14.

Sold Out: BridgeBio Pharma Inc (BBIO)

Parkman Healthcare Partners LLC sold out a holding in BridgeBio Pharma Inc. The sale prices were between $11.38 and $53.41, with an estimated average price of $42.17.

Sold Out: Vericel Corp (VCEL)

Parkman Healthcare Partners LLC sold out a holding in Vericel Corp. The sale prices were between $35.2 and $52.6, with an estimated average price of $43.64.

Reduced: DexCom Inc (DXCM)

Parkman Healthcare Partners LLC reduced to a holding in DexCom Inc by 27.61%. The sale prices were between $519.49 and $651.26, with an estimated average price of $575.47. The stock is now traded at around $381.240000. The impact to a portfolio due to this sale was -1.74%. Parkman Healthcare Partners LLC still held 32,906 shares as of 2021-12-31.

Reduced: Aclaris Therapeutics Inc (ACRS)

Parkman Healthcare Partners LLC reduced to a holding in Aclaris Therapeutics Inc by 21.5%. The sale prices were between $12.27 and $18.49, with an estimated average price of $15.09. The stock is now traded at around $13.260000. The impact to a portfolio due to this sale was -1.28%. Parkman Healthcare Partners LLC still held 1,025,522 shares as of 2021-12-31.

Reduced: Insulet Corp (PODD)

Parkman Healthcare Partners LLC reduced to a holding in Insulet Corp by 50.5%. The sale prices were between $255.32 and $318.29, with an estimated average price of $290.04. The stock is now traded at around $234.180000. The impact to a portfolio due to this sale was -1.25%. Parkman Healthcare Partners LLC still held 17,000 shares as of 2021-12-31.

Reduced: Arcus Biosciences Inc (RCUS)

Parkman Healthcare Partners LLC reduced to a holding in Arcus Biosciences Inc by 50.52%. The sale prices were between $31.38 and $48.47, with an estimated average price of $39.08. The stock is now traded at around $30.490000. The impact to a portfolio due to this sale was -1.06%. Parkman Healthcare Partners LLC still held 117,099 shares as of 2021-12-31.

Reduced: Avid Bioservices Inc (CDMO)

Parkman Healthcare Partners LLC reduced to a holding in Avid Bioservices Inc by 35.56%. The sale prices were between $20.7 and $34.18, with an estimated average price of $28.79. The stock is now traded at around $19.360000. The impact to a portfolio due to this sale was -0.87%. Parkman Healthcare Partners LLC still held 290,000 shares as of 2021-12-31.



Here is the complete portfolio of Parkman Healthcare Partners LLC. Also check out:

1. Parkman Healthcare Partners LLC's Undervalued Stocks
2. Parkman Healthcare Partners LLC's Top Growth Companies, and
3. Parkman Healthcare Partners LLC's High Yield stocks
4. Stocks that Parkman Healthcare Partners LLC keeps buying
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles